VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,987,000 | +44.4% | 171,970 | -1.1% | 0.02% | +41.2% |
| Q1 2018 | $2,762,000 | -30.2% | 173,814 | -8.3% | 0.02% | -22.7% |
| Q4 2017 | $3,955,000 | +35.0% | 189,499 | -7.1% | 0.02% | +37.5% |
| Q3 2017 | $2,929,000 | -15.5% | 204,066 | +2.0% | 0.02% | -15.8% |
| Q2 2017 | $3,466,000 | +61.1% | 200,096 | +2.5% | 0.02% | +58.3% |
| Q1 2017 | $2,151,000 | -28.9% | 195,156 | -6.6% | 0.01% | -33.3% |
| Q4 2016 | $3,026,000 | -37.1% | 209,043 | +6.4% | 0.02% | -40.0% |
| Q3 2016 | $4,813,000 | +24.5% | 196,508 | +2.0% | 0.03% | +15.4% |
| Q2 2016 | $3,865,000 | -12.4% | 192,564 | +14.6% | 0.03% | -21.2% |
| Q1 2016 | $4,410,000 | -73.3% | 167,959 | +1.8% | 0.03% | -73.6% |
| Q4 2015 | $16,529,000 | -41.7% | 164,951 | +3.4% | 0.12% | -46.8% |
| Q3 2015 | $28,360,000 | -23.2% | 159,574 | -3.5% | 0.24% | -10.0% |
| Q2 2015 | $36,918,000 | +13.3% | 165,351 | -0.0% | 0.26% | +17.0% |
| Q1 2015 | $32,578,000 | +78.1% | 165,381 | +29.6% | 0.22% | +57.0% |
| Q4 2014 | $18,295,000 | +8.7% | 127,598 | -0.4% | 0.14% | +6.8% |
| Q3 2014 | $16,828,000 | +4.7% | 128,108 | +0.7% | 0.13% | +8.1% |
| Q2 2014 | $16,076,000 | -9.9% | 127,168 | -6.3% | 0.12% | -15.2% |
| Q1 2014 | $17,839,000 | +17.5% | 135,691 | +4.1% | 0.14% | +14.2% |
| Q4 2013 | $15,180,000 | +18.7% | 130,301 | +6.1% | 0.13% | +13.4% |
| Q3 2013 | $12,792,000 | +55.9% | 122,816 | +29.8% | 0.11% | +34.9% |
| Q2 2013 | $8,205,000 | – | 94,633 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |